Ownership and insider activity for Accuray Incorporated (ARAY): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region.
Price
| Price | $0.24 |
| Market Cap | $29M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-29 | TCW GROUP INC | J-Other | 7,987,743 | $80K |
| 2026-07-29 | TCW GROUP INC | J-Other | 598,114 | $6K |
| 2026-05-29 | Miele Paul Michael | A-Award | 650,000 | |
| 2026-05-19 | TCW GROUP INC | J-Other | 1,414,040 | $2.1M |
| 2026-05-19 | TCW GROUP INC | J-Other | 1,010,028 | $1.3M |
| 2026-05-19 | TCW GROUP INC | J-Other | 808,023 | $8K |
| 2026-05-19 | TCW GROUP INC | J-Other | 105,882 | $159K |
| 2026-05-19 | TCW GROUP INC | J-Other | 75,630 | $95K |
| 2026-05-19 | TCW GROUP INC | J-Other | 60,504 | $605 |
| 2026-06-16 | TCW GROUP INC | 77,469 | $97K |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72.1M | $83.1M | $76.8M | $107.6M | $116.4M | $88.7M | $89.4M | $68.6M | $57.4M | $41.2M |
| Short-term Investments | $23.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $72.8M | $66.0M | $111.9M | $90.6M | $85.4M | $101.5M | $87.3M | $98.9M | $97.9M | $67.4M |
| Inventory | $105.1M | $108.5M | $120.8M | $134.4M | $125.9M | $142.3M | $145.2M | $138.3M | $141.0M | $147.1M |
| Total Current Assets | $309.0M | $284.2M | $344.1M | $357.5M | $352.8M | $350.9M | $338.0M | $323.2M | $317.5M | $287.5M |
| Property, Plant & Equipment | $23.1M | $23.7M | $17.1M | $44.0M | $34.9M | $29.5M | $46.8M | $58.5M | $61.8M | $54.8M |
| Goodwill | $57.8M | $57.9M | $57.8M | $57.7M | $58.0M | $57.8M | $57.7M | $57.7M | $57.8M | $57.9M |
| Intangible Assets | $964000 | $821000 | $679000 | $663000 | $435000 | $250000 | $210000 | $59000 | $15000 | 0 |
| Total Assets | $406.5M | $378.7M | $438.2M | $490.9M | $480.1M | $472.8M | $479.2M | $468.6M | $470.2M | $443.7M |
| Accounts Payable | $17.5M | $19.7M | $29.6M | $23.1M | $19.5M | $31.3M | $33.7M | $50.0M | $34.0M | $40.6M |
| Short-term Debt | $113.0M | 0 | 0 | 0 | $3.8M | $8.6M | $5.7M | $7.8M | $12.7M | $9.7M |
| Total Current Liabilities | $284.5M | $169.4M | $192.2M | $182.3M | $192.4M | $208.9M | $198.6M | $195.3M | $192.6M | $191.4M |
| Long-term Debt | $51.5M | $131.1M | $159.8M | $189.3M | $170.0M | $171.9M | $171.6M | $164.4M | $123.8M | $146.4M |
| Total Liabilities | $359.9M | $330.1M | $388.3M | $427.3M | $411.3M | $419.7M | $425.6M | $423.5M | $389.1M | $402.0M |
| Retained Earnings | -$450.4M | -$474.3M | -$485.5M | -$481.7M | -$488.0M | -$492.5M | -$502.1M | -$517.7M | -$519.3M | -$568.5M |
| Total Equity | $46.5M | $48.6M | $49.9M | $63.6M | $68.8M | $53.2M | $53.7M | $45.1M | $81.2M | $41.7M |
| Total Debt | $164.6M | $131.1M | $159.8M | $221.7M | $199.4M | $199.5M | $205.0M | $210.7M | $176.4M | $183.9M |
| Net Debt | $68.6M | $48.0M | $83.0M | $114.1M | $83.0M | $110.8M | $115.6M | $142.2M | $119.0M | $142.6M |
| Working Capital | $24.5M | $114.7M | $151.9M | $175.2M | $160.4M | $142.0M | $139.4M | $128.0M | $124.9M | $96.1M |
Financial Health
| Debt / Equity | 4.41 |
| Current Ratio | 1.50 |
Profitability
| Return on Equity | -99.04% |
| Return on Invested Capital | -10.09% |
| Return on Assets | -11.09% |
| Gross Margin | 27.73% |
| Operating Margin | -6.58% |
| Net Margin | -12.24% |
Related companies: ANIK · AVR · LNSR · MIST · MXCT · OWLT · PROF
Explore sector: Healthcare · Medical - Devices
More sections of ARAY: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks